Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Rcnet 50 mg Capsule
Manufacturer/Marketed By : BDR Pharmaceuticals Pvt Ltd
$20.40 $15.91
Sidmex Inovia offers bulk export supply of Rcnet 50 mg Capsule (Sunitinib 50 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain...
Sunitinib 50 mg
Active Pharmaceutical Ingredient
Rcnet 50 mg Capsule
$20.40
$15.91
Sidmex Inovia offers bulk export supply of Rcnet 50 mg Capsule (Sunitinib 50 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Rcnet 25 mg Capsule
Rcnet 50 mg capsules are a targeted anticancer therapy designed to combat various malignancies, including pancreatic cancer, gastrointestinal stromal tumors, and renal cell carcinoma. This innovative medication functions by inhibiting the proliferation of cancer cells, effectively slowing down tumor growth and potentially improving patient outcomes. It is important to follow your healthcare provider’s instructions carefully while using Rcnet, as it may lead to side effects such as nausea, fatigue, or changes in blood counts. Regular monitoring through blood tests is essential to ensure safety during treatment. As with any cancer therapy, discussions about potential risks and benefits with your physician are crucial before starting Rcnet. This capsule represents a vital option in the fight against cancer, offering hope to those diagnosed with challenging conditions. For optimal effectiveness, it should be combined with a comprehensive treatment plan tailored to each patient's needs. Always store Rcnet capsules in a cool, dry place, away from children, to maintain their efficacy.
Active Pharmaceutical Ingredient
Uses
• Rcnet 50 mg capsule is primarily indicated for the treatment of Advanced Renal Cell Carcinoma (RCC). This form of kidney cancer arises from the cells in the small tubes of the kidney. By targeting the cancerous cells, Rcnet 50 mg capsule helps in managing the progression of this disease. Patients diagnosed with RCC may benefit significantly from this treatment option.
• In patients with Advanced Renal Cell Carcinoma, Rcnet 50 mg capsule plays a crucial role in therapeutic management. It is designed to inhibit tumor growth and improve overall patient outcomes. The use of Rcnet 50 mg capsule is particularly relevant in advanced cases where other treatment options may be limited. This medication can provide a more effective approach to controlling cancer spread.
• Rcnet 50 mg capsule is often prescribed when conventional therapies are insufficient for managing Advanced Renal Cell Carcinoma. It works by specifically targeting pathways that contribute to cancer cell survival and proliferation. Patients may experience stabilization of their condition while on Rcnet 50 mg capsule. This treatment is an important part of a comprehensive cancer care plan.
• For individuals diagnosed with Advanced Renal Cell Carcinoma, Rcnet 50 mg capsule represents a valuable therapeutic agent. It helps in slowing the disease's advancement and can enhance the quality of life for patients. The administration of Rcnet 50 mg capsule is typically part of a broader treatment regimen tailored to each patient’s needs. Oncologists often recommend this medication as a key component of RCC management.
Benefits
Rcnet 50 mg is used to treat specific forms of cancer, such as gastrointestinal stroma tumors (GISTs), renal cell carcinoma (RCC), and imatinib-resistant GIST. The advantages of using Rcnet Capsule may involve reducing the size of cancerous tumors, slowing the progression and spread of cancer, alleviating cancer-related symptoms, and potentially extending survival in some individuals.
Side Effects
Like all medicines, Rcnet 50 mg Capsule may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Complete or Partial hair loss
• Change in hair and skin colour
• Back pain
• Stomach upset
• Dry skin
• Diarrhea
• Swollen eyes
• Tingling sensation in limbs
• Nausea and Vomiting
• Tiredness
• Muscle spasms
Common Side Effects
• Headache
• Blistered palm
• Rashes
• Sores on mouth or tongue
• Bleeding
• Swollen and Painful limbs
• decreased vision
• Blood in stool
• Fast heartbeat
• Sweating
• Hypertension
• Painful urination
• Unusual weight gain
• Trouble breathing
• serious side effects
• Dizziness
• Fatal skin reaction
How To Use
You may take this medicine with or without a meal. It is recommended that you swallow the tablet whole with a full glass of water and that you do not crush, chew, or break the tablet. If you miss a dose of this medicine, take it as soon as you can. Skip the missed dose and return to your regular dosing schedule if it is almost time for your next dose. Do not take a double dose of your medicine to make up for a missed dose.
Safety Advice
• Alcohol: Drinking alcohol while taking Rcnet 50 mg Capsule is generally not recommended. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol intake while taking any medication.
• Kidney: It is safe to use Rcnet Capsule in patients with kidney disease. No dose adjustment of Rcnet 50 mg Capsule is recommended. If you experience any side effects, please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Rcnet 50. Rcnet 50 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Rcnet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Rcnet 50 mg Capsule is safe for use in patients with mild to moderate liver disease, no dose adjustment of Rcnet 50 mg is recommended. The use of Rcnet is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Rcnet 50 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Rcnet Capsule during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Rcnet 50 mg Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Rcnet 50.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.